| Year |
Citation |
Score |
| 2021 |
Dufeys C, Daskalopoulos EP, Castanares-Zapatero D, Conway SJ, Ginion A, Bouzin C, Ambroise J, Bearzatto B, Gala JL, Heymans S, Papageorgiou AP, Vinckier S, Cumps J, Balligand JL, Vanhaverbeke M, et al. AMPKα1 deletion in myofibroblasts exacerbates post-myocardial infarction fibrosis by a connexin 43 mechanism. Basic Research in Cardiology. 116: 10. PMID 33564961 DOI: 10.1007/s00395-021-00846-y |
0.3 |
|
| 2020 |
Montiel V, Bella R, Michel LYM, Esfahani H, De Mulder D, Robinson EL, Deglasse JP, Tiburcy M, Chow PH, Jonas JC, Gilon P, Steinhorn B, Michel T, Beauloye C, Bertrand L, ... ... Balligand JL, et al. Inhibition of aquaporin-1 prevents myocardial remodeling by blocking the transmembrane transport of hydrogen peroxide. Science Translational Medicine. 12. PMID 33028705 DOI: 10.1126/scitranslmed.aay2176 |
0.783 |
|
| 2020 |
Schobesberger S, Wright PT, Poulet C, Sanchez Alonso Mardones JL, Mansfield C, Friebe A, Harding SE, Balligand JL, Nikolaev VO, Gorelik J. β-Adrenoceptor redistribution impairs NO/cGMP/PDE2 signalling in failing cardiomyocytes. Elife. 9. PMID 32228862 DOI: 10.7554/Elife.52221 |
0.345 |
|
| 2020 |
Dubois-Deruy E, Gelinas R, Beauloye C, Esfahani H, Michel LYM, Dessy C, Bertrand L, Balligand JL. Beta 3 adrenoreceptors protect from hypertrophic remodelling through AMP-activated protein kinase and autophagy. Esc Heart Failure. PMID 32154661 DOI: 10.1002/Ehf2.12648 |
0.362 |
|
| 2020 |
Dei Zotti F, Verdoy R, Brusa D, Lobysheva II, Balligand JL. Redox regulation of nitrosyl-hemoglobin in human erythrocytes. Redox Biology. 34: 101399. PMID 31838004 DOI: 10.1016/J.Redox.2019.101399 |
0.38 |
|
| 2020 |
Montiel V, Bella R, Michel L, Robinson E, Jonas J, Michel T, Beauloye C, Bertrand L, Ghigo A, Geninatti-Crich S, Yool A, Zimmermann W, Roderick L, Devuyst O, Balligand J. Inhibition of the water channel aquaporin-1 prevents myocardial remodeling by blocking the transmembrane transport of hydrogen peroxide European Heart Journal. 41. DOI: 10.1093/ehjci/ehaa946.3665 |
0.6 |
|
| 2019 |
André E, De Pauw A, Verdoy R, Brusa D, Bouzin C, Timmermans A, Bertrand L, Balligand JL. Changes of metabolic phenotype of cardiac progenitor cells during differentiation: Neutral effect of stimulation of AMP-activated protein kinase. Stem Cells and Development. PMID 31530214 DOI: 10.1089/Scd.2019.0129 |
0.371 |
|
| 2019 |
Turkieh A, Porouchani S, Beseme O, Chwastyniak M, Amouyel P, Lamblin N, Balligand JL, Bauters C, Pinet F. Increased clusterin levels after myocardial infarction is due to a defect in protein degradation systems activity. Cell Death & Disease. 10: 608. PMID 31406108 DOI: 10.1038/S41419-019-1857-X |
0.342 |
|
| 2018 |
Maack C, Eschenhagen T, Hamdani N, Heinzel FR, Lyon AR, Manstein DJ, Metzger J, Papp Z, Tocchetti CG, Birhan Yilmaz M, Anker SD, Balligand JL, Bauersachs J, Brutsaert D, Carrier L, et al. Treatments targeting inotropy. European Heart Journal. PMID 30295807 DOI: 10.1093/Eurheartj/Ehy600 |
0.313 |
|
| 2018 |
Dei Zotti F, Lobysheva II, Balligand JL. Nitrosyl-hemoglobin formation in rodent and human venous erythrocytes reflects NO formation from the vasculature in vivo. Plos One. 13: e0200352. PMID 29995915 DOI: 10.1371/Journal.Pone.0200352 |
0.352 |
|
| 2018 |
van der Velden J, Gabriele Tocchetti C, Varricchi G, Bianco A, Sequeira V, Hilfiker-Kleiner D, Hamdani N, Leite-Moreira A, Mayr M, Falcão-Pires I, Thum T, Dawson DK, Balligand JL, Heymans S. Metabolic changes in hypertrophic cardiomyopathies: Scientific update from the Working Group of Myocardial Function of the European Society of Cardiology. Cardiovascular Research. PMID 29912308 DOI: 10.1093/Cvr/Cvy147 |
0.318 |
|
| 2018 |
Turkieh A, Fertin M, Bouvet M, Mulder P, Drobecq H, Lemesle G, Lamblin N, de Groote P, Porouchani S, Chwastyniak M, Beseme O, Amouyel P, Mouquet F, Balligand JL, Richard V, et al. Expression and Implication of Clusterin in Left Ventricular Remodeling After Myocardial Infarction. Circulation. Heart Failure. 11: e004838. PMID 29891738 DOI: 10.1161/Circheartfailure.117.004838 |
0.335 |
|
| 2018 |
Mailleux F, Beauloye C, Balligand JL, Horman S, Bertrand L. Studying the Role of AMPK in Cardiac Hypertrophy and Protein Synthesis. Methods in Molecular Biology (Clifton, N.J.). 1732: 321-342. PMID 29480485 DOI: 10.1007/978-1-4939-7598-3_21 |
0.415 |
|
| 2018 |
Farah C, Michel LYM, Balligand JL. Nitric oxide signalling in cardiovascular health and disease. Nature Reviews. Cardiology. PMID 29388567 DOI: 10.1038/Nrcardio.2017.224 |
0.381 |
|
| 2018 |
Gélinas R, Mailleux F, Dontaine J, Bultot L, Demeulder B, Ginion A, Daskalopoulos EP, Esfahani H, Dubois-Deruy E, Lauzier B, Gauthier C, Olson AK, Bouchard B, Des Rosiers C, Viollet B, ... ... Balligand JL, et al. AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation. Nature Communications. 9: 374. PMID 29371602 DOI: 10.1038/S41467-017-02795-4 |
0.331 |
|
| 2018 |
Montiel V, Esfahani H, Mulder DD, Deglasse JP, Jonas JC, Steinhorn B, Michel T, Devuyst O, Balligand JL. 35Cardiac aquaporin-1 mediates transmembrane transport of hydrogen peroxide and modulates myocardial fibrosis and hypertrophic remodeling Cardiovascular Research. 114. DOI: 10.1093/Cvr/Cvy060.015 |
0.755 |
|
| 2018 |
Balligand J. Nitric oxide synthases, oxidant stress and cardiac remodeling Free Radical Biology and Medicine. 120. DOI: 10.1016/J.Freeradbiomed.2018.04.056 |
0.478 |
|
| 2017 |
Hermida N, Michel L, Esfahani H, Dubois-Deruy E, Hammond J, Bouzin C, Markl A, Colin H, Steenbergen AV, De Meester C, Beauloye C, Horman S, Yin X, Mayr M, Balligand JL. Cardiac myocyte β3-adrenergic receptors prevent myocardial fibrosis by modulating oxidant stress-dependent paracrine signaling. European Heart Journal. PMID 29106524 DOI: 10.1093/Eurheartj/Ehx366 |
0.417 |
|
| 2017 |
De Pauw A, Andre E, Sekkali B, Bouzin C, Esfahani H, Barbier N, Loriot A, De Smet C, Vanhoutte L, Moniotte S, Gerber B, di Mauro V, Catalucci D, Feron O, Hilfiker-Kleiner D, ... Balligand JL, et al. Dnmt3a-mediated inhibition of Wnt in cardiac progenitor cells improves differentiation and remote remodeling after infarction. Jci Insight. 2. PMID 28614798 DOI: 10.1172/Jci.Insight.91810 |
0.564 |
|
| 2017 |
Balligand JL, Michel LYM. Letter by Balligand and Michel Regarding Article, "Adrenergic Receptors in Individual Ventricular Myocytes: the Beta-1 and Alpha-1B Are in All Cells, the Alpha-1A Is in a Subpopulation, and the Beta-2 and Beta-3 Are Mostly Absent". Circulation Research. 120: e54-e55. PMID 28596176 DOI: 10.1161/Circresaha.117.310942 |
0.409 |
|
| 2017 |
Lobysheva II, Eeckhoudt SV, Zotti FD, Rifahi A, Pothen L, Beauloye C, Balligand JL. Clinical and biochemical data of endothelial function in Women Consuming Combined Contraceptives. Data in Brief. 13: 46-52. PMID 28560282 DOI: 10.1016/J.Dib.2017.05.019 |
0.31 |
|
| 2017 |
Lobysheva II, van Eeckhoudt S, Dei Zotti F, Rifahi A, Pothen L, Beauloye C, Balligand JL. Heme-nitrosylated hemoglobin and oxidative stress in women consuming combined contraceptives. Clinical application of the EPR spectroscopy. Free Radical Biology & Medicine. 108: 524-532. PMID 28392282 DOI: 10.1016/J.Freeradbiomed.2017.03.039 |
0.335 |
|
| 2017 |
Vanhoutte L, Guilbaud C, Martherus R, Bouzin C, Gallez B, Dessy C, Balligand JL, Moniotte S, Feron O. MRI Assessment of Cardiomyopathy Induced by β1-Adrenoreceptor Autoantibodies and Protection Through β3-Adrenoreceptor Overexpression. Scientific Reports. 7: 43951. PMID 28276515 DOI: 10.1038/Srep43951 |
0.508 |
|
| 2017 |
Balligand JL. Cardiac beta3-adrenergic receptors in the clinical arena: the end of the beginning. European Journal of Heart Failure. 19: 576-578. PMID 28198065 DOI: 10.1002/Ejhf.784 |
0.342 |
|
| 2017 |
Van Steenbergen A, Balteau M, Ginion A, Ferté L, Battault S, Ravenstein CM, Balligand JL, Daskalopoulos EP, Gilon P, Despa F, Despa S, Vanoverschelde JL, Horman S, Koepsell H, Berry G, et al. Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart. Scientific Reports. 7: 41166. PMID 28128227 DOI: 10.1038/Srep41166 |
0.39 |
|
| 2016 |
Michel LY, Balligand JL. New and Emerging Therapies and Targets: Beta-3 Agonists. Handbook of Experimental Pharmacology. PMID 28035527 DOI: 10.1007/164_2016_88 |
0.419 |
|
| 2016 |
De Pauw A, Massion P, Sekkali B, Andre E, Dubroca C, Kmecova J, Bouzin C, Friart A, Sibille C, Gilon P, De Mulder D, Esfahani H, Strapart A, Martherus R, Payen V, ... ... Balligand JL, et al. Paracrine Nitric Oxide induces expression of cardiac sarcomeric proteins in adult progenitor cells through soluble Guanylyl Cyclase/cyclic-GMP and Wnt/β-catenin inhibition. Cardiovascular Research. PMID 27520736 DOI: 10.1093/Cvr/Cvw196 |
0.46 |
|
| 2016 |
Vanhoutte L, Gerber BL, Gallez B, Po C, Magat J, Balligand JL, Feron O, Moniotte S. Erratum to: High field magnetic resonance imaging of rodents in cardiovascular research. Basic Research in Cardiology. 111: 55. PMID 27492500 DOI: 10.1007/S00395-016-0572-3 |
0.453 |
|
| 2016 |
Clouet S, Di Pietrantonio L, Daskalopoulos EP, Esfahani H, Horckmans M, Vanorlé M, Lemaire A, Balligand JL, Beauloye C, Boeynaems JM, Communi D. Loss of Mouse P2Y6 Nucleotide Receptor Is Associated with Physiological Macrocardia and Amplified Pathological Cardiac Hypertrophy. The Journal of Biological Chemistry. 291: 15841-52. PMID 27231349 DOI: 10.1074/jbc.M115.684118 |
0.305 |
|
| 2016 |
Balligand JL. Cardiac salvage by tweaking with beta-3-adrenergic receptors. Cardiovascular Research. 111: 128-33. PMID 27001422 DOI: 10.1093/Cvr/Cvw056 |
0.481 |
|
| 2016 |
Balligand J. β-Adrenergic Receptors Cooperate With Transcription Factors: The "STAT" of Their Union. Circulation. 133: 4-7. PMID 26628620 DOI: 10.1161/Circulationaha.115.019860 |
0.381 |
|
| 2016 |
Zotti FD, Lobysheva I, Balligand J. 0460 : Nitric oxide and hemoglobin form a paramagnetic compound quantifiable by Electron Paramagnetic Resonance (EPR) spectroscopy in venous erythrocytes that reflects vascular NO bioavailability in vivo Archives of Cardiovascular Diseases Supplements. 8: 217. DOI: 10.1016/S1878-6480(16)30401-3 |
0.401 |
|
| 2015 |
Balligand JL. KLF6 orchestrates cardiac myocyte-to-fibroblast communication: 'He who has ears to hear, let him hear'. Cardiovascular Research. 107: 397-9. PMID 26139526 DOI: 10.1093/Cvr/Cvv189 |
0.371 |
|
| 2015 |
Vanhoutte L, Gallez B, Feron O, Balligand JL, Esfahani H, d'Hoore W, Moniotte S. Variability of Mouse Left Ventricular Function Assessment by 11.7 Tesla MRI. Journal of Cardiovascular Translational Research. 8: 362-71. PMID 26070905 DOI: 10.1007/S12265-015-9638-0 |
0.508 |
|
| 2015 |
Horckmans M, Esfahani H, Beauloye C, Clouet S, di Pietrantonio L, Robaye B, Balligand JL, Boeynaems JM, Dessy C, Communi D. Loss of mouse P2Y4 nucleotide receptor protects against myocardial infarction through endothelin-1 downregulation. Journal of Immunology (Baltimore, Md. : 1950). 194: 1874-81. PMID 25595790 DOI: 10.4049/jimmunol.1401364 |
0.303 |
|
| 2015 |
Trappanese DM, Liu Y, McCormick RC, Cannavo A, Nanayakkara G, Baskharoun MM, Jarrett H, Woitek FJ, Tillson DM, Dillon AR, Recchia FA, Balligand JL, Houser SR, Koch WJ, Dell'Italia LJ, et al. Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy. Basic Research in Cardiology. 110: 456. PMID 25480109 DOI: 10.1007/S00395-014-0456-3 |
0.428 |
|
| 2015 |
Mailleux F, Gélinas R, Demeulder B, Ginion A, Hue L, Hammond J, Balligand J, Vanoverschelde J, Beauloye C, Horman S, Bertrand L. 0296 : Regulating O-GlcNAcylation by AMP-activated protein kinase, a new way to prevent hypertrophy development Archives of Cardiovascular Diseases Supplements. 7: 190-191. DOI: 10.1016/S1878-6480(15)30161-0 |
0.398 |
|
| 2014 |
Noppe G, Dufeys C, Buchlin P, Marquet N, Castanares-Zapatero D, Balteau M, Hermida N, Bouzin C, Esfahani H, Viollet B, Bertrand L, Balligand JL, Vanoverschelde JL, Beauloye C, Horman S. Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1. Journal of Molecular and Cellular Cardiology. 74: 32-43. PMID 24805196 DOI: 10.1016/J.Yjmcc.2014.04.018 |
0.416 |
|
| 2014 |
Timmermans AD, Balteau M, Gélinas R, Renguet E, Ginion A, de Meester C, Sakamoto K, Balligand JL, Bontemps F, Vanoverschelde JL, Horman S, Beauloye C, Bertrand L. A-769662 potentiates the effect of other AMP-activated protein kinase activators on cardiac glucose uptake. American Journal of Physiology. Heart and Circulatory Physiology. 306: H1619-30. PMID 24748590 DOI: 10.1152/Ajpheart.00965.2013 |
0.355 |
|
| 2014 |
Tarone G, Balligand JL, Bauersachs J, Clerk A, De Windt L, Heymans S, Hilfiker-Kleiner D, Hirsch E, Iaccarino G, Knöll R, Leite-Moreira AF, Lourenço AP, Mayr M, Thum T, Tocchetti CG. Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology. European Journal of Heart Failure. 16: 494-508. PMID 24639064 DOI: 10.1002/Ejhf.62 |
0.406 |
|
| 2014 |
Götz KR, Sprenger JU, Perera RK, Steinbrecher JH, Lehnart SE, Kuhn M, Gorelik J, Balligand JL, Nikolaev VO. Transgenic mice for real-time visualization of cGMP in intact adult cardiomyocytes. Circulation Research. 114: 1235-45. PMID 24599804 DOI: 10.1161/Circresaha.114.302437 |
0.349 |
|
| 2014 |
Belge C, Hammond J, Dubois-Deruy E, Manoury B, Hamelet J, Beauloye C, Markl A, Pouleur AC, Bertrand L, Esfahani H, Jnaoui K, Götz KR, Nikolaev VO, Vanderper A, Herijgers P, ... ... Balligand JL, et al. Enhanced expression of β3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase. Circulation. 129: 451-62. PMID 24190960 DOI: 10.1161/Circulationaha.113.004940 |
0.306 |
|
| 2014 |
Vanhoutte L, Esfahani H, Feron O, Balligand J, Gallez B, Moniotte S. P781Assessment of the accuracy and reproducibility of left ventricular mass and volumes measurements in mice using an 11.7T MRI machine Cardiovascular Research. 103: S143.4-S143. DOI: 10.1093/Cvr/Cvu098.199 |
0.51 |
|
| 2014 |
Hermida N, Dubois-Deruy E, Hammond J, Hamelet J, Markl A, Mayr M, Balligand J. 309Protection from cardiac fibrosis is induced by beta3 adrenergic receptor in cardiac myocyte through inhibition of paracrine signalling to fibroblast : proteomic analysis of the myocyte secretome Cardiovascular Research. 103: S56.2-S56. DOI: 10.1093/CVR/CVU090.2 |
0.309 |
|
| 2014 |
Vanhoutte L, Esfahani H, Feron O, Balligand J, Bernard G, Moniotte S. 0331: Left ventricular systolic function assessment in a mouse model of cardiac hypertrophy using an 11.7T MRI scanner and comparison with ex-vivo measurements Archives of Cardiovascular Diseases Supplements. 6: 62. DOI: 10.1016/S1878-6480(14)71431-4 |
0.544 |
|
| 2014 |
Mailleux F, Gélinas R, Demeulder B, Hammond J, Ginion A, Hue L, Balligand J, Vanoverschelde J, Beauloye C, Horman S, Bertrand L. 0309: A-769662, a specific AMP-activated protein kinase (AMPK) activator, prevents cardiomyocyte hypertrophy independently of the already identified AMPK downstream targets Archives of Cardiovascular Diseases Supplements. 6: 57. DOI: 10.1016/S1878-6480(14)71419-3 |
0.404 |
|
| 2013 |
Lobysheva II, Biller P, Gallez B, Beauloye C, Balligand JL. Nitrosylated hemoglobin levels in human venous erythrocytes correlate with vascular endothelial function measured by digital reactive hyperemia. Plos One. 8: e76457. PMID 24130774 DOI: 10.1371/Journal.Pone.0076457 |
0.345 |
|
| 2013 |
Balligand JL. Reducing damage through Nrf-2. Cardiovascular Research. 100: 1-3. PMID 23970486 DOI: 10.1093/Cvr/Cvt204 |
0.349 |
|
| 2013 |
Hirsch E, Hilfiker-Kleiner D, Balligand JL, Tarone G, De Windt L, Bauersachs J, Ferdinandy P, Davidson S, Hausenloy DJ, Schulz R. Interaction of the heart and its close and distant neighbours: report of the Meeting of the ESC Working Groups Myocardial Function and Cellular Biology. Cardiovascular Research. 99: 595-9. PMID 23860811 DOI: 10.1093/Cvr/Cvt179 |
0.316 |
|
| 2013 |
Hermida N, Markl A, Hamelet J, Van Assche T, Vanderper A, Herijgers P, Van Bilsen M, Hilfiker-Kleiner D, Noppe G, Beauloye C, Horman S, Balligand JL. HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome Cardiovascular Research. 99: 44-54. PMID 23542580 DOI: 10.1093/Cvr/Cvt070 |
0.384 |
|
| 2013 |
Ozakca I, Arioglu-Inan E, Esfahani H, Altan VM, Balligand JL, Kayki-Mutlu G, Ozcelikay AT. Nebivolol prevents desensitization of β-adrenoceptor signaling and induction of cardiac hypertrophy in response to isoprenaline beyond β1-adrenoceptor blockage. American Journal of Physiology. Heart and Circulatory Physiology. 304: H1267-76. PMID 23457011 DOI: 10.1152/Ajpheart.00352.2012 |
0.342 |
|
| 2013 |
Lenaerts I, Driesen RB, Hermida N, Blanco NH, Holemans P, Heidbüchel H, Janssens S, Balligand JL, Sipido KR, Willems R. Role of nitric oxide and oxidative stress in a sheep model of persistent atrial fibrillation. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 15: 754-60. PMID 23419660 DOI: 10.1093/Europace/Eut012 |
0.348 |
|
| 2013 |
Balligand JL. Beta3-adrenoreceptors in cardiovasular diseases: new roles for an "old" receptor. Current Drug Delivery. 10: 64-6. PMID 22998044 DOI: 10.2174/1567201811310010011 |
0.488 |
|
| 2013 |
Balligand JL, Hammond J. Protein kinase G type I in cardiac myocytes: unmasked at last? European Heart Journal. 34: 1181-5. PMID 22199118 DOI: 10.1093/Eurheartj/Ehr415 |
0.413 |
|
| 2013 |
Vanhoutte L, Feron O, Balligand J, Gallez B, Esfahani H, Moniotte S. Intra-observer, inter-experiment and inter-observer variability of left ventricular volumes and mass measurements in mice using an 11.7 Tesla MRI Journal of Cardiovascular Magnetic Resonance. 15. DOI: 10.1186/1532-429X-15-S1-P282 |
0.531 |
|
| 2013 |
Lenaerts I, Driesen RB, Blanco NH, Holemans P, Heidbüchel H, Janssens S, Balligand J, Sipido KR, Willems R. Corrigendumto:Role of nitric oxide and oxidative stress in a sheep model of persistent atrial fibrillation Europace (2013) 15 (5): 754-760 first published online February 17, 2013 doi:10.1093/europace/eut012 Europace. 15: 1684-1684. DOI: 10.1093/Europace/Eut342 |
0.334 |
|
| 2012 |
Horckmans M, Léon-Gómez E, Robaye B, Balligand JL, Boeynaems JM, Dessy C, Communi D. Gene deletion of P2Y4 receptor lowers exercise capacity and reduces myocardial hypertrophy with swimming exercise. American Journal of Physiology. Heart and Circulatory Physiology. 303: H835-43. PMID 22865387 DOI: 10.1152/Ajpheart.00256.2012 |
0.339 |
|
| 2012 |
Horckmans M, Robaye B, Léon-Gόmez E, Lantz N, Unger P, Dol-Gleizes F, Clouet S, Cammarata D, Schaeffer P, Savi P, Gachet C, Balligand JL, Dessy C, Boeynaems JM, Communi D. P2Y(4) nucleotide receptor: a novel actor in post-natal cardiac development. Angiogenesis. 15: 349-60. PMID 22437266 DOI: 10.1007/S10456-012-9265-1 |
0.454 |
|
| 2012 |
Manoury B, Montiel V, Balligand JL. Nitric oxide synthase in post-ischaemic remodelling: new pathways and mechanisms. Cardiovascular Research. 94: 304-15. PMID 22227153 DOI: 10.1093/Cvr/Cvr360 |
0.466 |
|
| 2012 |
Hammond J, Balligand JL. Nitric oxide synthase and cyclic GMP signaling in cardiac myocytes: from contractility to remodeling. Journal of Molecular and Cellular Cardiology. 52: 330-40. PMID 21843527 DOI: 10.1016/J.Yjmcc.2011.07.029 |
0.411 |
|
| 2012 |
Nanka O, Krejci E, Pesevski Z, Sedmera D, Smart N, Rossdeutsch A, Dube KN, Riegler J, Price AN, Taylor A, Muthurangu V, Turner M, Lythgoe MF, Riley PR, Kryvorot S, ... ... Balligand JL, et al. Poster session 3 Cardiovascular Research. 93: S92-S127. DOI: 10.1093/Cvr/Cvr336 |
0.357 |
|
| 2011 |
Hoch M, Fischer P, Stapel B, Missol-Kolka E, Sekkali B, Scherr M, Favret F, Braun T, Eder M, Schuster-Gossler K, Gossler A, Hilfiker A, Balligand JL, Drexler H, Hilfiker-Kleiner D. Erythropoietin preserves the endothelial differentiation capacity of cardiac progenitor cells and reduces heart failure during anticancer therapies. Cell Stem Cell. 9: 131-43. PMID 21816364 DOI: 10.1016/J.Stem.2011.07.001 |
0.431 |
|
| 2011 |
Knöll R, Iaccarino G, Tarone G, Hilfiker-Kleiner D, Bauersachs J, Leite-Moreira AF, Sugden PH, Balligand JL. Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC. European Journal of Heart Failure. 13: 811-9. PMID 21708908 DOI: 10.1093/Eurjhf/Hfr071 |
0.395 |
|
| 2011 |
Lobysheva I, Rath G, Sekkali B, Bouzin C, Feron O, Gallez B, Dessy C, Balligand JL. Moderate caveolin-1 downregulation prevents NADPH oxidase-dependent endothelial nitric oxide synthase uncoupling by angiotensin II in endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology. 31: 2098-105. PMID 21659644 DOI: 10.1161/Atvbaha.111.230623 |
0.579 |
|
| 2011 |
Gauthier C, Rozec B, Manoury B, Balligand JL. Beta-3 adrenoceptors as new therapeutic targets for cardiovascular pathologies. Current Heart Failure Reports. 8: 184-92. PMID 21633786 DOI: 10.1007/S11897-011-0064-6 |
0.397 |
|
| 2011 |
Sorrentino SA, Doerries C, Manes C, Speer T, Dessy C, Lobysheva I, Mohmand W, Akbar R, Bahlmann F, Besler C, Schaefer A, Hilfiker-Kleiner D, Lüscher TF, Balligand JL, Drexler H, et al. Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional β1-blockade. Journal of the American College of Cardiology. 57: 601-11. PMID 21272752 DOI: 10.1016/J.Jacc.2010.09.037 |
0.357 |
|
| 2010 |
Dessy C, Balligand JL. Beta3-adrenergic receptors in cardiac and vascular tissues emerging concepts and therapeutic perspectives. Advances in Pharmacology (San Diego, Calif.). 59: 135-63. PMID 20933201 DOI: 10.1016/S1054-3589(10)59005-7 |
0.383 |
|
| 2010 |
Dessy C, Feron O, Balligand JL. The regulation of endothelial nitric oxide synthase by caveolin: a paradigm validated in vivo and shared by the 'endothelium-derived hyperpolarizing factor'. Pflugers Archiv : European Journal of Physiology. 459: 817-27. PMID 20339866 DOI: 10.1007/S00424-010-0815-3 |
0.579 |
|
| 2010 |
Ni J, McLoughlin RM, Brodovitch A, Moulin P, Brouckaert P, Casadei B, Feron O, Topley N, Balligand JL, Devuyst O. Nitric oxide synthase isoforms play distinct roles during acute peritonitis. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 25: 86-96. PMID 19706695 DOI: 10.1093/Ndt/Gfp415 |
0.53 |
|
| 2009 |
Balligand J, Feron O, Dessy C. eNOS Activation by Physical Forces: From Short-Term Regulation of Contraction to Chronic Remodeling of Cardiovascular Tissues Physical Review. 89: 481-534. PMID 19342613 DOI: 10.1152/Physrev.00042.2007 |
0.621 |
|
| 2009 |
Heymans S, Hirsch E, Anker SD, Aukrust P, Balligand JL, Cohen-Tervaert JW, Drexler H, Filippatos G, Felix SB, Gullestad L, Hilfiker-Kleiner D, Janssens S, Latini R, Neubauer G, Paulus WJ, et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure. 11: 119-29. PMID 19168509 DOI: 10.1093/Eurjhf/Hfn043 |
0.309 |
|
| 2009 |
Morel N, Vandenberg G, Ahrabi AK, Caron N, Desjardins F, Balligand JL, Horie S, Devuyst O. PKD1 haploinsufficiency is associated with altered vascular reactivity and abnormal calcium signaling in the mouse aorta. PflüGers Archiv : European Journal of Physiology. 457: 845-56. PMID 18679710 DOI: 10.1007/S00424-008-0561-Y |
0.303 |
|
| 2008 |
Zelarayán LC, Noack C, Sekkali B, Kmecova J, Gehrke C, Renger A, Zafiriou MP, van der Nagel R, Dietz R, de Windt LJ, Balligand JL, Bergmann MW. Beta-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation. Proceedings of the National Academy of Sciences of the United States of America. 105: 19762-7. PMID 19073933 DOI: 10.1073/Pnas.0808393105 |
0.367 |
|
| 2008 |
Desjardins F, Lobysheva I, Pelat M, Gallez B, Feron O, Dessy C, Balligand JL. Control of blood pressure variability in caveolin-1-deficient mice: role of nitric oxide identified in vivo through spectral analysis. Cardiovascular Research. 79: 527-36. PMID 18349137 DOI: 10.1093/Cvr/Cvn080 |
0.579 |
|
| 2008 |
Billon A, Lehoux S, Lam Shang Leen L, Laurell H, Filipe C, Benouaich V, Brouchet L, Dessy C, Gourdy P, Gadeau AP, Tedgui A, Balligand JL, Arnal JF. The estrogen effects on endothelial repair and mitogen-activated protein kinase activation are abolished in endothelial nitric-oxide (NO) synthase knockout mice, but not by NO synthase inhibition by N-nitro-L-arginine methyl ester. The American Journal of Pathology. 172: 830-8. PMID 18276789 DOI: 10.2353/Ajpath.2008.070439 |
0.414 |
|
| 2008 |
Saliez J, Bouzin C, Rath G, Ghisdal P, Desjardins F, Rezzani R, Rodella LF, Vriens J, Nilius B, Feron O, Balligand JL, Dessy C. Role of caveolar compartmentation in endothelium-derived hyperpolarizing factor-mediated relaxation: Ca2+ signals and gap junction function are regulated by caveolin in endothelial cells. Circulation. 117: 1065-74. PMID 18268148 DOI: 10.1161/Circulationaha.107.731679 |
0.541 |
|
| 2008 |
Desjardins F, Sekkali B, Verreth W, Pelat M, De Keyzer D, Mertens A, Smith G, Herregods MC, Holvoet P, Balligand JL. Rosuvastatin increases vascular endothelial PPARgamma expression and corrects blood pressure variability in obese dyslipidaemic mice. European Heart Journal. 29: 128-37. PMID 18063594 DOI: 10.1093/Eurheartj/Ehm540 |
0.305 |
|
| 2007 |
Moniotte S, Belge C, Sekkali B, Massion P, Rozec B, Dessy C, Balligand J. Sepsis is associated with an upregulation of functional beta3 adrenoceptors in the myocardium. European Journal of Heart Failure. 9: 1163-1171. PMID 17999941 DOI: 10.1016/J.Ejheart.2007.10.006 |
0.35 |
|
| 2007 |
Massion PB, Balligand JL. Relevance of nitric oxide for myocardial remodeling. Current Heart Failure Reports. 4: 18-25. PMID 17386181 DOI: 10.1007/S11897-007-0021-6 |
0.442 |
|
| 2007 |
Dubroca C, Loyer X, Retailleau K, Loirand G, Pacaud P, Feron O, Balligand JL, Lévy BI, Heymes C, Henrion D. RhoA activation and interaction with Caveolin-1 are critical for pressure-induced myogenic tone in rat mesenteric resistance arteries. Cardiovascular Research. 73: 190-7. PMID 17150200 DOI: 10.1016/J.Cardiores.2006.10.020 |
0.53 |
|
| 2006 |
Desjardins F, Balligand J. Nitric oxide-dependent endothelial function and cardiovascular disease. Acta Clinica Belgica. 61: 326-334. PMID 17323842 DOI: 10.1179/Acb.2006.052 |
0.426 |
|
| 2006 |
Batova S, DeWever J, Godfraind T, Balligand JL, Dessy C, Feron O. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells. Cardiovascular Research. 71: 478-85. PMID 16814758 DOI: 10.1016/J.Cardiores.2006.04.013 |
0.563 |
|
| 2006 |
Sbaa E, Dewever J, Martinive P, Bouzin C, Frérart F, Balligand JL, Dessy C, Feron O. Caveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesis. Circulation Research. 98: 1219-27. PMID 16601228 DOI: 10.1161/01.Res.0000220648.80170.8B |
0.556 |
|
| 2006 |
Feron O, Balligand JL. Caveolins and the regulation of endothelial nitric oxide synthase in the heart. Cardiovascular Research. 69: 788-97. PMID 16483868 DOI: 10.1016/J.Cardiores.2005.12.014 |
0.634 |
|
| 2006 |
Dessy C, Saliez J, Ghisdal P, Daneau G, Lobysheva II, Frérart F, Belge C, Jnaoui K, Noirhomme P, Feron O, Balligand JL. Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol. Circulation. 112: 1198-205. PMID 16116070 DOI: 10.1161/Circulationaha.104.532960 |
0.549 |
|
| 2006 |
Moniotte S, Balligand J. Potential use of beta(3)-adrenoceptor antagonists in heart failure therapy. Cardiovascular Drug Reviews. 20: 19-26. PMID 12070531 DOI: 10.1111/J.1527-3466.2002.Tb00079.X |
0.36 |
|
| 2005 |
Balligand J. La Donna è Mobile...": is cardiac neuronal nitric oxide synthase such a disconcerting enzyme? Circulation. 112: 3668-3671. PMID 16344396 DOI: 10.1161/Circulationaha.105.588236 |
0.472 |
|
| 2005 |
Belge C, Massion PB, Pelat M, Balligand J. Nitric oxide and the heart: update on new paradigms. Annals of the New York Academy of Sciences. 1047: 173-182. PMID 16093495 DOI: 10.1196/Annals.1341.016 |
0.47 |
|
| 2005 |
Massion PB, Pelat M, Belge C, Balligand J. Regulation of the mammalian heart function by nitric oxide. Comparative Biochemistry and Physiology a-Molecular & Integrative Physiology. 142: 144-150. PMID 15985381 DOI: 10.1016/J.Cbpb.2005.05.048 |
0.48 |
|
| 2005 |
Schulz R, Rassaf T, Massion P, Kelm M, Balligand J. Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis. Pharmacology & Therapeutics. 108: 225-256. PMID 15949847 DOI: 10.1016/J.Pharmthera.2005.04.005 |
0.386 |
|
| 2004 |
Pelat M, Balligand J. Statins and hypertension. Seminars in Vascular Medicine. 4: 367-375. PMID 15861317 DOI: 10.1055/S-2004-869593 |
0.302 |
|
| 2004 |
Massion PB, Dessy C, Desjardins F, Pelat M, Havaux X, Belge C, Moulin P, Guiot Y, Feron O, Janssens S, Balligand JL. Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction. Circulation. 110: 2666-72. PMID 15492314 DOI: 10.1161/01.Cir.0000145608.80855.Bc |
0.647 |
|
| 2004 |
Dessy C, Moniotte S, Ghisdal P, Havaux X, Noirhomme P, Balligand J. Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization. Circulation. 110: 948-954. PMID 15302798 DOI: 10.1161/01.Cir.0000139331.85766.Af |
0.348 |
|
| 2004 |
Sonveaux P, Martinive P, DeWever J, Batova Z, Daneau G, Pelat M, Ghisdal P, Grégoire V, Dessy C, Balligand JL, Feron O. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis. Circulation Research. 95: 154-61. PMID 15205364 DOI: 10.1161/01.Res.0000136344.27825.72 |
0.584 |
|
| 2004 |
Sonveaux P, Dessy C, Martinive P, Havaux X, Jordan BF, Gallez B, Grégoire V, Balligand JL, Feron O. Endothelin-1 is a critical mediator of myogenic tone in tumor arterioles: implications for cancer treatment. Cancer Research. 64: 3209-14. PMID 15126361 DOI: 10.1158/0008-5472.Can-03-1291 |
0.484 |
|
| 2004 |
Attia DM, Feron O, Goldschmeding R, Radermakers LH, Vaziri ND, Boer P, Balligand JL, Koomans HA, Joles JA. Hypercholesterolemia in rats induces podocyte stress and decreases renal cortical nitric oxide synthesis via an angiotensin II type 1 receptor-sensitive mechanism. Journal of the American Society of Nephrology : Jasn. 15: 949-57. PMID 15034097 DOI: 10.1097/01.Asn.0000118528.00817.8E |
0.511 |
|
| 2003 |
Ni J, Moulin P, Gianello P, Feron O, Balligand JL, Devuyst O. Mice that lack endothelial nitric oxide synthase are protected against functional and structural modifications induced by acute peritonitis. Journal of the American Society of Nephrology : Jasn. 14: 3205-16. PMID 14638919 DOI: 10.1097/01.Asn.0000099382.18284.57 |
0.55 |
|
| 2003 |
Massion PB, Feron O, Dessy C, Balligand JL. Nitric oxide and cardiac function: ten years after, and continuing. Circulation Research. 93: 388-98. PMID 12958142 DOI: 10.1161/01.Res.0000088351.58510.21 |
0.636 |
|
| 2003 |
Pelat M, Dessy C, Massion P, Desager JP, Feron O, Balligand JL. Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo. Circulation. 107: 2480-6. PMID 12719275 DOI: 10.1161/01.Cir.0000065601.83526.3E |
0.571 |
|
| 2003 |
Sonveaux P, Brouet A, Havaux X, Grégoire V, Dessy C, Balligand JL, Feron O. Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. Cancer Research. 63: 1012-9. PMID 12615716 |
0.495 |
|
| 2003 |
Piech A, Dessy C, Havaux X, Feron O, Balligand JL. Differential regulation of nitric oxide synthases and their allosteric regulators in heart and vessels of hypertensive rats. Cardiovascular Research. 57: 456-67. PMID 12566118 DOI: 10.1016/S0008-6363(02)00676-4 |
0.572 |
|
| 2003 |
Massion P, Balligand J. Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice The Journal of Physiology. 546: 63-75. PMID 12509479 DOI: 10.1113/Jphysiol.2002.025973 |
0.473 |
|
| 2003 |
Pelat M, Dessy C, Massion P, Desager J, Feron O, Balligand J. 4P-1061 Altered blood pressure and heart rate variability in hypercholesterolemic apoE-/-mice is corrected by rosuvastatin independently of its plasma lipid lowering activity Atherosclerosis Supplements. 4: 308. DOI: 10.1016/S1567-5688(03)91318-3 |
0.451 |
|
| 2002 |
Sonveaux P, Dessy C, Brouet A, Jordan BF, Grégoire V, Gallez B, Balligand JL, Feron O. Modulation of the tumor vasculature functionality by ionizing radiation accounts for tumor radiosensitization and promotes gene delivery. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 16: 1979-81. PMID 12397083 DOI: 10.1096/Fj.02-0487Fje |
0.495 |
|
| 2002 |
Balligand J. Heat shock protein 90 in endothelial nitric oxide synthase signaling: following the lead(er)? Circulation Research. 90: 838-841. PMID 11988482 DOI: 10.1161/01.Res.0000018173.10175.Ff |
0.403 |
|
| 2002 |
Persu A, Stoenoiu MS, Messiaen T, Davila S, Robino C, El-Khattabi O, Mourad M, Horie S, Feron O, Balligand JL, Wattiez R, Pirson Y, Chauveau D, Lens XM, Devuyst O. Modifier effect of ENOS in autosomal dominant polycystic kidney disease Human Molecular Genetics. 11: 229-241. PMID 11823442 DOI: 10.1093/Hmg/11.3.229 |
0.512 |
|
| 2002 |
Piech A, Massart P, Dessy C, Feron O, Havaux X, Morel N, Vanoverschelde J, Donckier J, Balligand J. Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy American Journal of Physiology-Heart and Circulatory Physiology. 282. PMID 11748066 DOI: 10.1152/Ajpheart.2002.282.1.H219 |
0.624 |
|
| 2001 |
Massion PB, Moniotte S, Balligand J. Nitric oxide: does it play a role in the heart of the critically ill? Current Opinion in Critical Care. 7: 323-336. PMID 11805529 DOI: 10.1097/00075198-200110000-00003 |
0.47 |
|
| 2001 |
Brouet A, Sonveaux P, Dessy C, Moniotte S, Balligand JL, Feron O. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins. Circulation Research. 89: 866-73. PMID 11701613 DOI: 10.1161/Hh2201.100319 |
0.575 |
|
| 2001 |
Brouet A, Sonveaux P, Dessy C, Balligand JL, Feron O. Hsp90 ensures the transition from the early Ca2+-dependent to the late phosphorylation-dependent activation of the endothelial nitric-oxide synthase in vascular endothelial growth factor-exposed endothelial cells. The Journal of Biological Chemistry. 276: 32663-9. PMID 11425855 DOI: 10.1074/Jbc.M101371200 |
0.559 |
|
| 2001 |
Moniotte S, Kobzik L, Feron O, Trochu JN, Gauthier C, Balligand JL. Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation. 103: 1649-55. PMID 11273992 DOI: 10.1161/01.Cir.103.12.1649 |
0.545 |
|
| 2001 |
Feron O, Dessy C, Desager JP, Balligand JL. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation. 103: 113-8. PMID 11136695 DOI: 10.1161/01.Cir.103.1.113 |
0.578 |
|
| 2000 |
Gauthier C, Langin D, Balligand J. Beta3-adrenoceptors in the cardiovascular system. Trends in Pharmacological Sciences. 21: 426-431. PMID 11121573 DOI: 10.1016/S0165-6147(00)01562-5 |
0.361 |
|
| 2000 |
Dessy C, Kelly RA, Balligand JL, Feron O. Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling. The Embo Journal. 19: 4272-80. PMID 10944110 DOI: 10.1093/Emboj/19.16.4272 |
0.572 |
|
| 2000 |
Combet S, Balligand J, Lameire N, Goffin E, Devuyst O. A specific method for measurement of nitric oxide synthase enzymatic activity in peritoneal biopsies. Kidney International. 57: 332-338. PMID 10620216 DOI: 10.1046/J.1523-1755.2000.00839.X |
0.33 |
|
| 2000 |
Gauthier C, Leblais V, Moniotte S, Langin D, Balligand J. The negative inotropic action of catecholamines: Role of beta(3)-adrenoceptors Canadian Journal of Physiology and Pharmacology. 78: 681-690. DOI: 10.1139/Y00-045 |
0.376 |
|
| 1999 |
Balligand J. Regulation of cardiac beta-adrenergic response by nitric oxide. Cardiovascular Research. 43: 607-620. PMID 10690332 DOI: 10.1016/S0008-6363(99)00163-7 |
0.409 |
|
| 1999 |
Feron O, Dessy C, Moniotte S, Desager JP, Balligand JL. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. The Journal of Clinical Investigation. 103: 897-905. PMID 10079111 DOI: 10.1172/Jci4829 |
0.584 |
|
| 1998 |
Gauthier C, Leblais V, Kobzik L, Trochu JN, Khandoudi N, Bril A, Balligand JL, Le Marec H. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. The Journal of Clinical Investigation. 102: 1377-84. PMID 9769330 DOI: 10.1172/JCI2191 |
0.323 |
|
| 1998 |
Arstall MA, Bailey C, Gross WL, Bak M, Balligand JL, Kelly RA. Reversible S-nitrosation of creatine kinase by nitric oxide in adult rat ventricular myocytes. Journal of Molecular and Cellular Cardiology. 30: 979-88. PMID 9618238 DOI: 10.1006/Jmcc.1998.0662 |
0.419 |
|
| 1998 |
Joe EK, Schussheim AE, Longrois D, Mäki T, Kelly RA, Smith TW, Balligand JL. Regulation of cardiac myocyte contractile function by inducible nitric oxide synthase (iNOS): mechanisms of contractile depression by nitric oxide. Journal of Molecular and Cellular Cardiology. 30: 303-15. PMID 9515007 DOI: 10.1006/Jmcc.1997.0593 |
0.452 |
|
| 1997 |
Balligand J, Cannon PJ. Nitric Oxide Synthases and Cardiac Muscle Autocrine and Paracrine Influences Arteriosclerosis, Thrombosis, and Vascular Biology. 17: 1846-1858. PMID 9351345 DOI: 10.1161/01.Atv.17.10.1846 |
0.478 |
|
| 1997 |
Fischer TA, Ungureanu-Longrois D, Singh K, de Zengotita J, DeUgarte D, Alali A, Gadbut AP, Lee MA, Balligand JL, Kifor I, Smith TW, Kelly RA. Regulation of bFGF expression and ANG II secretion in cardiac myocytes and microvascular endothelial cells. The American Journal of Physiology. 272: H958-68. PMID 9124460 DOI: 10.1152/Ajpheart.1997.272.2.H958 |
0.381 |
|
| 1997 |
Balligand JL, Kelly RA, Smith TW. Cardiac endothelium and tissue growth. Progress in Cardiovascular Diseases. 39: 351-60. PMID 9050820 DOI: 10.1016/S0033-0620(97)80033-3 |
0.455 |
|
| 1996 |
Smith TW, Balligand JL, Kaye DM, Wiviott SD, Simmons WW, Han X, Michel T, Singh K, Kelly RA. The role of the NO pathway in the control of cardiac function. Journal of Cardiac Failure. 2: S141-7. PMID 8951572 DOI: 10.1016/S1071-9164(96)80070-4 |
0.669 |
|
| 1996 |
Kelly RA, Balligand JL, Smith TW. Nitric oxide and cardiac function. Circulation Research. 79: 363-80. PMID 8781470 DOI: 10.1161/01.Res.79.3.363 |
0.481 |
|
| 1996 |
Gross WL, Bak MI, Ingwall JS, Arstall MA, Smith TW, Balligand JL, Kelly RA. Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve. Proceedings of the National Academy of Sciences of the United States of America. 93: 5604-9. PMID 8643623 DOI: 10.1073/Pnas.93.11.5604 |
0.403 |
|
| 1996 |
Belhassen L, Kelly RA, Smith TW, Balligand JL. Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. Regulation of NOS3 transcription in vitro and in vivo by cyclic adenosine monophosphate in rat cardiac myocytes. The Journal of Clinical Investigation. 97: 1908-15. PMID 8621775 DOI: 10.1172/Jci118622 |
0.475 |
|
| 1996 |
Kaye DM, Wiviott SD, Balligand JL, Simmons WW, Smith TW, Kelly RA. Frequency-dependent activation of a constitutive nitric oxide synthase and regulation of contractile function in adult rat ventricular myocytes. Circulation Research. 78: 217-24. PMID 8575064 DOI: 10.1161/01.Res.78.2.217 |
0.326 |
|
| 1996 |
Singh K, Balligand JL, Fischer TA, Smith TW, Kelly RA. Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular endothelial cells. Role of extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) and STAT1 alpha. The Journal of Biological Chemistry. 271: 1111-7. PMID 8557638 DOI: 10.1074/Jbc.271.2.1111 |
0.386 |
|
| 1996 |
Balligand J, Ungureanu-Longrois D, Smith TW. Role of a cytokine-inducible nitric oxide synthase in the control of myocardial contractile state Heart Failure Reviews. 1: 193-201. DOI: 10.1007/Bf00127808 |
0.488 |
|
| 1995 |
Ungureanu-Longrois D, Balligand JL, Simmons WW, Okada I, Kobzik L, Lowenstein CJ, Kunkel SL, Michel T, Kelly RA, Smith TW. Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to beta-adrenergic agonists. Circulation Research. 77: 494-502. PMID 7543826 DOI: 10.1161/01.Res.77.3.494 |
0.593 |
|
| 1995 |
Ungureanu-Longrois D, Balligand JL, Okada I, Simmons WW, Kobzik L, Lowenstein CJ, Kunkel SL, Michel T, Kelly RA, Smith TW. Contractile responsiveness of ventricular myocytes to isoproterenol is regulated by induction of nitric oxide synthase activity in cardiac microvascular endothelial cells in heterotypic primary culture. Circulation Research. 77: 486-93. PMID 7543825 DOI: 10.1161/01.Res.77.3.486 |
0.57 |
|
| 1995 |
Balligand JL, Kobzik L, Han X, Kaye DM, Belhassen L, O'Hara DS, Kelly RA, Smith TW, Michel T. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. The Journal of Biological Chemistry. 270: 14582-6. PMID 7540173 DOI: 10.1074/Jbc.270.24.14582 |
0.65 |
|
| 1995 |
Ungureanu-Longrois D, Balligand JL, Kelly RA, Smith TW. Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. Journal of Molecular and Cellular Cardiology. 27: 155-67. PMID 7539082 DOI: 10.1016/S0022-2828(08)80015-6 |
0.453 |
|
| 1995 |
Balligand JL, Ungureanu-Longrois D, Simmons WW, Kobzik L, Lowenstein CJ, Lamas S, Kelly RA, Smith TW, Michel T. Induction of NO synthase in rat cardiac microvascular endothelial cells by IL-1 beta and IFN-gamma. The American Journal of Physiology. 268: H1293-303. PMID 7535006 DOI: 10.1152/Ajpheart.1995.268.3.H1293 |
0.703 |
|
| 1995 |
Singh K, Balligand JL, Fischer TA, Smith TW, Kelly RA. Glucocorticoids increase osteopontin expression in cardiac myocytes and microvascular endothelial cells. Role in regulation of inducible nitric oxide synthase. The Journal of Biological Chemistry. 270: 28471-8. PMID 7499354 DOI: 10.1074/Jbc.270.47.28471 |
0.45 |
|
| 1994 |
Balligand JL, Ungureanu-Longrois D, Simmons WW, Pimental D, Malinski TA, Kapturczak M, Taha Z, Lowenstein CJ, Davidoff AJ, Kelly RA. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. Journal of Biological Chemistry. 269: 27580-27588. DOI: 10.1016/s0021-9258(18)47024-x |
0.332 |
|
| 1993 |
Balligand J, Ungureanu D, Kelly RA, Kobzik L, Pimental D, Michel T, Smith TW. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. Journal of Clinical Investigation. 91: 2314-2319. PMID 8486792 DOI: 10.1172/Jci116461 |
0.61 |
|
| 1993 |
Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system Proceedings of the National Academy of Sciences of the United States of America. 90: 347-351. PMID 7678347 DOI: 10.1073/Pnas.90.1.347 |
0.616 |
|
| 1992 |
Balligand J, Kelly RA, Smith TW, Michel T. Regulation of cardiac myocyte function by a constitutive no signalling pathway Journal of Molecular and Cellular Cardiology. 24: 177. DOI: 10.1016/0022-2828(92)90555-E |
0.584 |
|
| 1991 |
Balligand J, Godfraind T. Endothelium-derived Relaxing Factor and Muscle-derived Relaxing Factor in Rat Aorta - Action of Cyclosporine-a Journal of Cardiovascular Pharmacology. 17. DOI: 10.1097/00005344-199100001-00038 |
0.356 |
|
| Show low-probability matches. |